Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Between 05 to 26 February 2013.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study conducted in compliance with OECD Guideline No. 423 without any deviation.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 17 December 2001
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Inspected on 2012-04-23&24 / Signed on 2012-07-18.
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- 6-cyclopentylidenehexanal
- Cas Number:
- 111998-18-6
- Molecular formula:
- C11 H18 O
- IUPAC Name:
- 6-cyclopentylidenehexanal
- Test material form:
- liquid
- Details on test material:
- - Description: Colourless translucent liquid
- Storage conditions: Store in a cool, dry place with adequate ventilation. Keep away from incompatible materials, light, open flames, and high temperatures
Constituent 1
- Specific details on test material used for the study:
- - Date received: 23 January 2013
- Storage condition of test material: 6°C±3°C
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Elevage JANVIER (53940 Le Genest St Isle, France)
- Age at study initiation: 8 or 9 weeks
- Weight at study initiation: 185 - 219 g
- Housing: housed by group of three in solid-bottomed clear polycarbonate cages with a stainless steel mesh lid.
- Diet: foodstuff (SAFE, A04), ad libitum.
- Water: tap-water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 19-25 °C
- Humidity: 30-70%
- Air changes: between ten and fifteen changes per hour.
- Photoperiod: 12 h light/12 h darkness.
IN-LIFE DATES: From 05 to 26 February 2013.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: at 2000 mg/kg bw: none. At 300 mg/kg bw: water.
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2.15 mL/kg bw
ADMINISTRATION OF TEST ITEM:
* In the first step: animals received an effective dose of 2000 mg/kg bw of the test item, administered by force-feeding under a volume of 2.15 mL/kg bw using a suitable syringe graduated fitted with an oesophageal metal canula.
* In the second step: animals received an effective dose of 300 mg/kg bw of the test item (0.32 mL of the test item was added to 1.83 mL of distilled water), administered by force-feeding under a volume of 2.15 mL/kg bw using a suitable syringe graduated fitted with an oesophageal metal canula.
VEHICLE
- Amount of vehicle (if gavage): 1.83 mL (second step, at 300 mg/kg bw)
- Justification for choice of vehicle: no data
- Lot/batch no. (if required): no data - Doses:
- 300 and 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 (2000 mg/kg bw) and 6 (300 mg/kg bw)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed 30 min, 1, 3 and 4 hours after test item administration and thereafter once daily for 14 days. Animals were weighed pretest (Day 0) and on Day 2, 7 and 14.
- Necropsy of survivors performed: Yes; Animals were killed on Day 14 and subjected to macroscopic examination. - Statistics:
- None
Results and discussion
- Preliminary study:
- Not applicable
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- ca. 1 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- - At 2000 mg/kg b.w: it was noted the death of two rats (2/3), at 22 hours and 50 minutes post-dose.
- At 300 mg/kg b.w: no mortality occurred. - Clinical signs:
- other: - At 2000 mg/kg b.w: the mortalities were preceded by decrease in spontaneous activity (2/2) and piloerection (1/2). Rigor mortis was noted before the necropsy (2/2). In the surviving animal treated at 2000 mg/kg b.w. (1/3), a decrease in spontaneous act
- Gross pathology:
- - At 2000 mg/kg b.w: the macroscopic examination revealed a thinning of the forestomach and of the corpus (2/2) associated with black and red spots on the forestomach and on the corpus (2/2).
- At 300 mg/kg b.w: the macroscopical examination of the animals at the end of the study did not reveal treatment-related changes. - Other findings:
- None
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Under the test conditions, the oral LD50 for test item is higher than 300 mg/kg and lower than 2000 mg/kg bw and the LD50 cut-off may be considered as 1000 mg/kg bw in female rats. Therefore, it must be classified in Category 4 according to the CLP Regulation (EC) No. 1272/2008 and Globally Harmonized System (GHS).
- Executive summary:
In an acute oral toxicity study (limit test) performed according to OECD Guideline 423 and in compliance with GLP, 3 female Sprague Dawley rats were given a single oral (gavage) dose of test item at 2000 mg/kg bw and then 6 female Sprague Dawley rats were given a single oral (gavage) dose of test item at 300 mg/kg bw. Animals were then observed for mortality, clinical signs and bodyweights for 14 days and were all sacrificed for macroscopic examination.
It was noted the death of two rats treated at 2000 mg/kg b.w. (2/3). The mortalities were preceded by decrease in spontaneous activity (2/2) and piloerection (1/2). Rigor mortis was noted before the necropsy (2/2). Decrease in body weight was noted in the two animals on the day of the death compared to day 0 (between -11% and -15%) The macroscopic examination revealed a thinning of the forestomach and of the corpus (2/2) associated with black and red spots on the forestomach and on the corpus (2/2). In the surviving animal treated at 2000 mg/kg b.w. (1/3), a decrease in spontaneous activity, bradypnea, total ptosis, and piloerection were noted during the first days of the test. The animal recovered a normal behaviour at 48 hours post-dose. An absence in body weight gain was noted on day 2 compared to day 0. Then, the body weight evolution remained normal. The macroscopic examination of this animal at the end of the study did not reveal treatment related changes.
No mortality occurred in animals treated at 300 mg/kg. A decrease in spontaneous activity (3/6), and piloerection (2/6) were noted during the first hours of the test. The animals recovered a normal behaviour at 4 hours post-dose. The body weight evolution remained normal during the study.The macroscopic examination of the animals at the end of the study did not reveal treatment related changes.
Under the test conditions, the oral LD50 for test item is higher than 300 mg/kg and lower than 2000 mg/kg bw and the LD50 cut-off may be considered as 1000 mg/kg bw in female rats. Therefore, it must be classified in Category 4 (H302: Harmful if swallowed) according to the CLP Regulation (EC) No. 1272/2008 and Globally Harmonized System (GHS).
This study is considered as acceptable and satisfies the requirement for acute oral toxicity endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.